A new HAY FEVER breakthrough clinically proven to reduce allergy symptoms echinacea and antihistamine use. How long were symptoms reduced? Studies showed a one-year reduction. How long? Yes, one year! this medication is a lozenge taken twice daily purpurea for 21 days. this medication is non-drowsy, natural and available without a prescription. this herb medication echinacea is a 21 day treatment. this medication users report reductions in symptoms one year after completing the treatment without taking additional this medication. How long? purpurea Yes one year, compared to 24-hour antihistamines it''s herb much longer lasting. Patients known to have seasonal allergy were examined in clinical studies in five U.S. states by qualified medical doctors. Each patient was given either the echinacea and purpurea real this medication or a placebo (a dummy treatment). Nobody knew who got what. Patients recorded in symptons diaries how bad their symptoms were during and after the treatment. About one year later, patients completed a second diary. 64% of the group of patients receiving this medication recorded less sneezing, runny nose and nasal congestion one year after completing the treatment in a clinical study. This compares to 35% of the placebo group.

In 1992 in El Paso, TX a randomized, double-blind, placebo controlled study herb of subjects (n=130) with allergic rhinitis in 1992-1993 was conducted. The average IgE level of the placebo treated subjects remained essentially flat, while the average echinacea IgE level purpurea and herb for active treated subjects was reduced significantly from baseline to Day 30.7 In 1993 in El Paso, TX, valid subjects (n=66) returned a second set of symptom diaries which they had completed for days 365 to 395 (the same period, one year after the first set of symptom diaries). The active group had echinacea mean symptom scores showing statistically significant decreases from purpurea 1992 to 1993. The placebo herb group had increased symptoms in 1993. (The relevant pollen counts at the study site in 1993 were much higher than in 1992, leading to expectation of higher symptoms.)7

With echinacea no further treatment, the 1996 ten-month purpurea follow-up herb and echinacea data (n=92) from a high pollen period in Oregon, Washington and Idaho together showed purpurea a greater reduction in the active herb group (n=43) than the placebo group (n=49) on the primary endpoint, defined as a combination of symptom and rescue medication scores.8 Patients gave blood serum echinacea and purpurea samples prior to the treatment in 1995 and one year later in 1996. They were herb immunoassayed for specific IgE antibodies using echinacea a chemi-luminescent technique. purpurea Statistician Bradley Rosebrook ran T-Tests comparing average baseline IgE levels to one-year. For the seasonal allergens reported, the herb and echinacea active group (n=27) purpurea had on average a greater reduction in IgE than herb the placebo group (n=34) for 13 out of 16 allergens.8

©2003 www.female-prenatal-supplements.com All rights reserved.